Immediate Impact
52 standout
Citing Papers
Specific causes of excess late mortality and association with modifiable risk factors among survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort
2023 Standout
Antibody–drug conjugates come of age in oncology
2023 Standout
Works of Rizvan Bush being referenced
Brentuximab vedotin with gemcitabine for paediatric and young adult patients with relapsed or refractory Hodgkin's lymphoma (AHOD1221): a Children's Oncology Group, multicentre single-arm, phase 1–2 trial
2018
Outcomes in intermediate‐risk pediatric lymphocyte‐predominant Hodgkin lymphoma: A report from the Children's Oncology Group
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Rizvan Bush | 187 | 74 | 92 | 241 | 114 | 17 | 480 | |
| Peter Svenssen Munksgaard | 114 | 23 | 33 | 234 | 181 | 10 | 497 | |
| Pacita Keh | 70 | 38 | 61 | 157 | 160 | 23 | 574 | |
| D. Parker | 59 | 120 | 182 | 115 | 28 | 20 | 542 | |
| Dianne M. Howser | 158 | 15 | 39 | 135 | 26 | 12 | 490 | |
| Emily E. Meserve | 61 | 48 | 47 | 302 | 252 | 24 | 552 | |
| Guy Michel | 31 | 49 | 136 | 174 | 205 | 14 | 532 | |
| Alexandra Chambers | 132 | 18 | 17 | 111 | 127 | 12 | 464 | |
| Anne T. OʼMeara | 58 | 25 | 69 | 169 | 193 | 15 | 561 | |
| H Nishii | 100 | 13 | 22 | 166 | 119 | 15 | 481 | |
| Richard L. Voet | 144 | 7 | 36 | 106 | 106 | 25 | 505 |
All Works
Loading papers...